KyungDong Pharm Co., Ltd. launches ‘Ledoron Tablets/Syrup’, a cough treatment for acute and chronic bronchitis, on May 1, 2019.

 

‘Ledoron Tablet’ is a tablet containing 60mg of levodropropizine.

‘Ledoron Syrup’ is a 500mL strawberry-flavored colorless syrup containing 600mg of levodropropizine per 100mL.

 

Acute bronchitis is a common disease that accounts for the largest proportion of outpatients in recent years.

In particular, the number of both adults and children is steadily increasing due to the continuously worsening fine dust.

‘Ledoron tablets/syrup’ is an antitussive expectorant that effectively relieves coughing symptoms in patients with bronchitis.

 

In particular, ‘Ledoron tablets/syrup’ is a peripheral antitussive that acts directly on cough receptors such as the nose and bronchial tubes.

It has a rapid and effective antitussive effect compared to central antitussive drugs, which have a high risk of addiction or misuse.

It is characterized by a low incidence of adverse reactions such as drowsiness, making it relatively safe to prescribe.

 

In addition, it can be prescribed in combination with other antitussive expectorants, so its utility can be said to be high.

 

‘Ledoron tablets/syrup’, which has excellent effectiveness, safety, and high usability, is widely used in various medical departments.

It is expected to be an item that will drive growth in KyungDong Pharm's sales.

  

♤ Product Information ♤

Product Name

Ledoron Tablets

Ledoron Syrup

Ingredient content

Levodropropizine 60mg

Levodropropizine 600mg/100mL

Indications

Cough due to the following diseases: acute/chronic bronchitis

Dosage and usage

Adults: 60mg 3 times a day

Administer orally at least 6 hours apart

Adults: 60mg 3 times a day

10~20kg: 18mg 3 times a day

20~30kg: 30mg 3 times a day

Administer orally at least 6 hours apart

Packaging unit

30T/bottle, 300T/bottle

500mL/bottle

※ Please refer to the product manual for other details such as precautions for use.